Association of ACE gene polymorphism and diabetic nephropathy?

Kidney International

Volumn 47, Issue 4, 1995, Pages 1176-1181

  Schmidt, Susanne ^a   Schöne, Nina ^a   Ritz, Eberhard ^a   Gießel, Roland ^a,b   Bergis, Kristian ^a,b   Strojek, Krzysztof ^a,c   Greszczak, Wladyslaw ^a,c   Schröter, Wolfgang ^a,d   Willms, Berend H L ^a,d   Petzold, Rüdiger ^a,e   Henrichs, Helmut R ^a,f   Rambausek, Michael ^a,g   Schwarzbeck, Andreas ^a,h   Köhr, Beate ^a,h   Schneider, Peter ^a,h   Bosch, Alfred ^a,i  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Diabetes Clinic   (Germany)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d Diabetes Center   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f Diabetes Center   (Germany)

^g Dialysis Center Heilbronn   (Germany)

^h Dialysis Centre   (Germany)

ⁱ NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0028937003     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.167     Document Type: Article

References (40)

1. SEAQUIST ER, GOETZ FC, RICH S, BARBOSA J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
2. PETTITT DJ, SAAD MF, BENNETT PH, NELSON RG, KNOWLER WC: Familial predisposition to renal disease in two generations of Pima Indians with type II (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
3. ANDERSON S, RENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension. J Clin Invest 77:1993-2000, 1986
4. LIEBERMANN J, SASTRE A: Serum angiotensin-converting enzyme: Elevations in diabetes mellitus. Ann Intern Med 93:825-826, 1980
5. HALLAB M, BLED F, EBRAN JM, SURANITI S, GIRAULT A, FRESSINAUD P, MARRE M: Elevated serum angiotensin converting enzyme activity in type I, insulin dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 29:82-85, 1992
6. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
7. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENC-GELAS F: Angiotensin I converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993
8. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU JP, ARVEILER D, LUC G, BARD JM, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin converting enzyme is a potential risk factor for myocardial infarction. Nature 359:641-644, 1992
9. RAYNOLDS MV, BRISTOW MR, BUSH EW, ABRAHAM WT, LOWES BD, ZISMAN LS, TAFT CS, PERRYMAN BM: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-1075, 1993
10. SCHUNKERT H, HENSE H-W, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GAJ: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
11. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, THAM-TAM G, HALLAB M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
12. NATIONAL DIABETES DATA GROUP: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
13. WHO Expert Committee on Diabetes mellitus (1980) World Health Organisation Technical Report Series 640. Geneva
14. RIGAT B, HUBERT C, CORVOL P, SOUBRIER F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). (abstract) Nucl Acids Res 20:1433, 1992
15. GRAHAM DE: The isolation of high molecular weight DNA from whole organisms or large tissue masses. Anal Biochem 85:609-613, 1978
16. MILLER SA, DYKES DD, POLESKY HF: A simple salting out procedure for extracting DNA from human nucleated cells. (abstract) Nucl Acids Res 16:1215, 1988
17. SHANMUGAN V, SELL KW, SANA BK: Mistyping ACE heterozygotes. PCR Meth Appl 3:120-121, 1993
18. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
19. KROLEWSKI AS, WARRAM JH, RAND LI, KAHN CR: Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-1398, 1987
20. FORSBLOM CM, GROOP PH, EKSTRAND A, GROOP LC: Predictive value of microalbuminuria in insulin-dependent diabetes of long duration. Br Med J 305:1051-1053, 1992
21. LANE PH, STEFES MW, MAUER M: Glomerular Structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 41:581-586, 1992
22. RITZ E, KELLER CK, BERGIS HK, SIEBELS M: Renal involvement in type II diabetes. Curr Opin Nephrol Hypertens 3:137-144, 1994
23. PARVING HH, GALL MA, SKØOT P: Prevalence and causes of albuminuria in non-insulin dependent diabetic patients. Kidney Int 41:758-762, 1987
24. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU J-P, ARVEILER D, LUC G, BARD J-M, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
25. SCHMIDT S, SCHÖNE N, GIESSEL R, BERGIS KH, RITZ E: Assoziation des ACE-Gen Polymorphismus mit diabetischer Nephropathie. 25. Congress Gesellschaft Nephrologie, Zürich, 25-28 September 1994 (abstract)
26. SCHMIDT S, VAN HOOFT IMS, GROBBEE DE, GANTEN D, RITZ E: Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 11:345-348, 1993
27. HARRAP SB, DAVIDSON HR, CONNOR JM, SOUBRIER F, CORVOL P, FRASER R, FOY CJW, WATT GCM: The angiotensin I converting enzyme gene and predisposition to hypertension. Hypertension 21: 455-460, 1993
28. HASSLACHER C, RITZ E, WAHL P, MICHAEL C: Similar risks of nephropathy in patients with type I and type II diabetes mellitus. Nephrol Dial Transplant 4:859-863, 1989
29. BENHAMOU PY, MARWAH T, BALDUCCI F, ZMIROU D, BORGEL F, CORDONNIER D, HALIMI S, PAPOZ L: Classification of diabetes in patients with endstage renal disease. Clin Nephrol 5:239-244, 1992
30. FROGUEL PH, VAXILLAIRE M, SUN F, VELHO G, ZOUALI H, BUTEL MO, LESAGE S, VIONNET N, CLÉMENT K, FOUGEROUSSE F, TANIZAWA Y, WEISSENBACH J, BECKMAN S, LATHROP GM, PASSA PH, PERMUTT MA, COHEN D: The glucokinase locus on chromosome 7p is closely linked to early onset non-insulin dependent diabetes mellitus. Nature 356:162-165, 1992
31. BORCH-JOHNSEN K, ANDERSEN PK, DECKERT T: The effect of protein-uria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985
32. CHRISTLIEB AR, KALDANY A, D'ELIA JA: Plasma renin activity and hypertension in diabetes mellitus. Diabetes 25:969-974, 1976
33. O'HARE JA, ROLAND JM, WALTERS G, CORRALL RJM: Impaired sodium excretion in response to volume expansion induced by water immersion in non-insulin-dependent diabetes mellitus. Clin Sci 71: 403-409, 1986
34. O'HARE JA, FERRIS BJ, BRADY D, TWOMEY B, O'SULLIVAN J: Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 7(Suppl II):II42-II48, 1985
35. DRURY PL, SMITH GM, FERRIS JB: Increased vasopressor responsiveness to angiotensin II in Type I (insulin-dependent) diabetic patients without complications. Diabetologia 27:174-179, 1984
36. MANN JF, LEIDIG M, RITZ E: Human angiotensin II receptors are regulated by angiotensin II. Clin Exp Hypertens 10:151-168, 1988
37. MAKARIOUS M, PAWLAK M, CAMPBELL LV, TIMMERMANS V, DUGGAN K, CHARLESWORTH JA, MACDONALD GJ: The platelet angiotensin II receptor in type I diabetes: Studies in patients with and without nephropathy. Eur J Clin Invest 23:517-521, 1993
38. LUETSCHER JA, KRAEMER FB, WILSON DM, SCHWARTZ HC, BRYERASH M: Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med 312:1412-1417, 1985
39. SCHALEKAMP MADH: Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease. Clin Invest 7 (Suppl):S3-S6, 1993
40. SEALY JE, LARAGH JH: The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis (chapt 80), in Hypertension. Pathophysiology, Diagnosis and Management, edited by JH LARAGH, BM BRENNER, New York, Raven Press, 1990, pp. 1287-1317